Tradestie Institutional Equity Comparison Engine

PDX vs USPH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

USPH Overall Edge

USPH Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to US Physical Therapy Inc (USPH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PDX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus USPH at 29.6x Forward P/E and 10.2% operating margin (+13.1% YoY). In options structure, PDX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against USPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner USPH
PDX N/M vs USPH 29.6x Fwd P/E
Growth & Margin Winner USPH
Op Margin N/A vs 10.2% ยท YoY N/A vs +13.1%
Momentum & Technical Winner USPH
1Y -7.7% vs +39.8% ยท 52W Pos 42% vs 95%
Options & Structure Winner USPH
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
PDX NYSE
PIMCO Dynamic Income Strategy Fund
Institutional Equity
$20.06
-0.5% 1D
Market Cap $1.1B
1M Return +0.2%
1Y Return -7.69%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 41.0 Fund 48.0 Flow 50.0 Mom 50.0
USPH NYSE
US Physical Therapy Inc
Services-Health Services
$99.55
-0.05% 1D
Market Cap $1.5B
1M Return +16.15%
1Y Return +39.78%
Forward P/E 29.6x
Unified AI Score
31.8 / 100 SELL
Tech 50.0 Fund 25.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PDX -7.69% USPH +39.78% Spread: +47.47 pp (USPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PDX TTM Op. Margin: N/A USPH TTM Op. Margin: 10.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PDX vs USPH. Trailing 12-month operating profitability (PDX N/A vs USPH 10.2%) and valuation multiples (PDX N/M vs USPH 29.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PDX (2) vs USPH (8)
Institutional Metric PDX USPH Criterion Row Winner
Market Capitalization Scale $1.1B $1.5B Larger Scale USPH
Trailing P/E Ratio Valuation N/M 32.9x Lower Multiple USPH
Forward P/E Ratio Valuation N/M 29.6x Lower Multiple USPH
Revenue Growth (YoY) Growth N/A +13.1% Higher Growth USPH
Operating Margin (TTM) Profitability N/A 10.2% Higher Margin USPH
Net Profit Margin Profitability N/A 3.6% Higher Margin USPH
Return on Equity (ROE) Capital Efficiency N/A 6.3% Higher ROE USPH
52-Week Range Position Momentum 42% ($18โ€“$22) 95% ($58โ€“$102) Stronger Trend USPH
Beta / 30D Volatility Risk Regime 0.19ฮฒ ยท 16% Vol 0.14ฮฒ ยท 42% Vol Lower Realized Risk PDX
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 31.8 / 100 (SELL) Higher Composite PDX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PDX vs USPH Buy Guide
PDX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
USPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live USPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PDX nor USPH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.